Skip to content
Independent Medical Alliance
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate
  • My Accountmy account
  • Home
    Latest Updates

    Stay up-to-date with the latest news from our fast-moving field.

    View
    Blog

    Subscribe to our blog to read our weekly news capsule and be the first to receive the latest announcements from IMA.

    Read Now
    In the News

    Read media coverage of IMA from around the world.

    View
  • TREATMENT
    Treatment Guidelines

    Strategies to prevent and treat COVID-19, Long COVID, RSV, Flu and Vaccine-related issues:

    • Prevention
    • Treatment
    • Long COVID Recovery
    • Vaccine Injury Prevention
    • Shedding from Vaccines
    • Long Vax Recovery

    Strategies to prevent and treat conditions like cancer, depression, insulin resistance and more:

    • Brain Health
    • Cancer Resource Hub
    • Depression & Mental Health
    • Fasting & Healthy Eating
    • Insulin Resistance
    • Sepsis
  • Resources
    Wondering where to begin?

    Let us help you find what you’re looking for. We know COVID-19 can be overwhelming; click below to learn more about the resources available to you on this website.

    get started
    Patient Resources
    • Find a Provider
    • Find a Pharmacy
    • Tools & Guides
    • Testimonials
    • FAQ
    Professional Resources
    • Journal of Independent Medicine

    • Research
    • Ivermectin Facts
    • Informed Consent
    • Join the Alliance
  • Education
    About the education portal

    IMA’s goal is to educate healthcare providers and empower patients with the tools and resources they need to take control of their own health.

    Education on Demand

    Stream video lectures, download slide presentations, and get exclusive access to key facts, data, and references from IMA (formerly FLCCC) educational programs.

    • My Content
    • Explore Courses
  • Community
    Events

    IMA hosts dynamic events that unite top experts from diverse fields for learning, sharing, and collaboration. Join us for unique in-person and virtual experiences that foster knowledge exchange and meaningful partnerships.

    • Weekly Webinar

    • Annual Conference
    Forums

    Join the discussion! IMA public and private forums are a place for the IMA community to connect without fear of censorship.

    • Forums
    Membership

    Explore IMA (formerly FLCCC) membership options for healthcare professionals and committed individuals who share a common passion and purpose. Members receive access to private forums and exclusive content and events while supporting IMA’s mission.

    • Join Now
    • Sign In
  • About
    About the IMA

    Learn about the history of IMA (formerly FLCCC), our mission and vision, and how you can get involved.

    learn more
    • Founders & Clinical Team
    • Senior Fellows
    • Contributors
    • Partners
    • Connect with Us
    • Advocacy
    • Impact Reports
    • Annual Reports
    • Support Us
    • Shop our Store
  • Search
    Search for:
  • IMA HOME
    • Latest UpdatesGet the latest updates from the FLCCC Alliance and their work on COVID-19 prevention and treatment.
    • Blog
    • In the NewsCheck out the latest in news coverage focused on the FLCCC Alliance and our members!
  • TREATMENT
    • Prevention
    • Treatment
    • Recovery
    • More Protocols
      • Brain Health
      • Cancer Resource Hub
      • Depression & Mental Health
      • Eat Well
      • Insulin Resistance
      • Sepsis Care
      • Shedding from Vaccines
  • RESOURCES
    • Journal of Independent Medicine
    • Research
    • Tools & Guides
    • Find a Provider
    • Find a Pharmacy
    • FAQ
    • Efficacy of Ivermectin
    • Join The Alliance
  • EDUCATION
    • Courses
  • COMMUNITY
    • Events
      • Annual Conference 2026
      • Weekly WebinarsJoin FLCCC’s live webinars every Wednesday at 7 pm ET for the latest updates on COVID news & treatment options. Hear from experts, get questions answered!
    • Forums
    • Membership
  • ABOUT
    • Founders & Clinical Team
    • Senior Fellows
    • IMA Contributors
    • Partners
    • Annual Reports
    • Impact Reports
    • Connect with Us
Independent Medical Alliance
  • MY ACCOUNT
  • MY FORUMS
  • MY COURSES
Search for:
  • Twitter
  • Rumble
  • Instagram
  • Connect with Us
Donate

References

Categories

Cancer Care (474) I-CARE Early Covid (187) I-CARE Flu and RSV (36) I-PREVENT (153) I-RECOVER Long Covid (111) I-RECOVER Post-Vaccine (320) MATH+ (288)

Tags

ACE2 protein (10) acute respiratory distress syndrome (21) Anti-inflammatory (13) Antidepressants (9) Ascorbic Acid (13) autoantibodies (10) autophagy (48) Breast Cancer (30) Cancer (69) Cancer Stem Cells (11) Chemotherapy (12) Colon Cancer (11) Corticosteroids (9) COVID-19 (330) COVID-19 Vaccines (8) Curcumin (14) Cytokines (13) Depression (12) Diabetes (14) Famotidine (14) Hydroxychloroquine (15) Hyperbaric Oxygen Therapy (9) Inflammation (15) intermittent fasting (14) ivermectin (53) long COVID (21) Macrophages (18) Mast Cells (8) Melatonin (23) Mitochondria (14) Myeloid Cells (10) Pneumonia (9) quercetin (15) resveratrol (11) SARS-CoV-2 (83) Sepsis (22) spermidine (11) Spike Protein (12) Thiamine (11) Thrombosis (9) Tinnitus (12) Tumor (41) Vitamin C (30) Vitamin D (29) Zinc (12)
  • Reference: Off-label use of topical minoxidil in alopecia: A review.

    Published On: April 1, 2019

    Authors: Stoehr JR, Choi JN, Colavincenzo M, Vanderweil S PMID: 30604379 DOI: 10.1007/s40257-018-0409-y Abstract Topical minoxidil is a well-known and often-utilized drug in dermatological practice for the treatment of alopecia. It was approved by the United States Food and Drug Administration for the treatment of androgenetic alopecia in 1988. Since its approval, minoxidil has been [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Alopecia

  • Reference: Non-invasive brain stimulation for the rehabilitation of children and adolescents with neurodevelopmental disorders: A systematic review.

    Published On: February 6, 2019

    Authors: Finisguerra A, Borgatti R, Urgesi C PMID: 30787895 PMCID: PMC6373438 DOI: 10.3389/fpsyg.2019.00135 Abstract In the last years, there has been a growing interest in the application of different non-invasive brain stimulation techniques to induce neuroplasticity and to modulate cognition and behavior in adults. Very recently, different attempts have been made to induce functional plastic [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Neurodevelopmental Disorders, Non-Invasive Brain Stimulation

  • Reference: Thrombolytic therapy for pulmonary embolism.

    Published On: December 18, 2018

    Authors: Beckman JA PMID: 30560579 PMCID: PMC6516871 doi: 10.1002/14651858.CD004437.pub5 AbstractBackgroundThrombolytic therapy is usually reserved for patients with clinically serious or massive pulmonary embolism (PE). Evidence suggests that thrombolytic agents may dissolve blood clots more rapidly than heparin and may reduce the death rate associated with PE. However, there are still concerns about the possible risk [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: pulmonary embolism, Thrombosis

  • Reference: Residual vision activation and the brain-eye-vascular triad: Dysregulation, plasticity and restoration in low vision and blindness – a review.

    Published On: November 27, 2018

    Authors: Sabel BA, Flammer J, Merabet LB PMID: 30412515 PMCID: PMC6294586 DOI: 10.3233/RNN-180880 Abstract Vision loss due to ocular diseases such as glaucoma, optic neuropathy, macular degeneration, or diabetic retinopathy, are generally considered an exclusive affair of the retina and/or optic nerve. However, the brain, through multiple indirect influences, has also a major impact on [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Blindness, Dysregulation, Low-Vision, Residual Vision Activation

  • Reference: Hydrocortisone, Ascorbic Acid and Thiamine (HAT therapy) for the treatment of sepsis. Focus on ascorbic acid.

    Published On: November 14, 2018

    Authors: Marik PE PMID: 30441816 doi: 10.3390/nu10111762 Abstract Sepsis is a devastating disease that carries an enormous toll in terms of human suffering and lives lost. Over 100 novel pharmacologic agents that targeted specific molecules or pathways have failed to improve the outcome of sepsis. Preliminary data suggests that the combination of Hydrocortisone, Ascorbic Acid [...]

    Categories: I-PREVENT, I-RECOVER Post-Vaccine, MATH+

    Tags: Ascorbic Acid, Hydrocortisone, Sepsis, Thiamine

  • Reference: The clinical value of using chloroquine or hydroxychloroquine as autophagy inhibitors in the treatment of cancers. A systematic review and meta-analysis.

    Published On: November 9, 2018

    Authors: Xu R, Ji Z, Xu C, Zhu J PMID: 30431566 PMCID: PMC6257684 doi: 10.1097/MD.0000000000012912 Abstract Background: Autophagy is a mechanism which relies on lysosomes for clearance and recycling of abnormal proteins or organelles. Many studies have demonstrated that the deregulation of autophagy is associated with the development of various diseases including cancer. The use [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: autophagy, Cancer, Hydroxychloroquine

  • Reference: Noninvasive brain stimulation in psychiatric disorders: a primer.

    Published On: October 11, 2018

    Authors: Brononi AR, Sampaio-Junior B, Moffa AH, Aparicio L, Gordon P, Klein I et al. PMID: 30328957 PMCID: PMC6781710 DOI: 10.1590/1516-4446-2017-0018 Abstract Objective: Noninvasive brain stimulation (NIBS) techniques, such as transcranial direct current stimulation (tDCS) and repetitive transcranial magnetic stimulation (rTMS), are increasingly being used to treat mental disorders, particularly major depression. The aim of [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Non-Invasive Brain Stimulation

  • Reference: Effect of hyperbaric oxygen therapy on chronic neurocognitive deficits of post-traumatic brain injury patients: retrospective analysis.

    Published On: September 28, 2018

    Authors: Hadanny A, Abbott S, Suzin G, Bechor Y, Efrati S PMID: 30269074 PMCID: PMC6169752 DOI: 10.1136/bmjopen-2018-023387 Abstract Objectives: The aim of the study is to evaluate the effect of hyperbaric oxygen therapy (HBOT) in participants suffering from chronic neurological deficits due to traumatic brain injury (TBI) of all severities in [...]

    Categories: I-RECOVER Post-Vaccine

    Tags: Hyperbaric Oxygen Therapy

  • Reference: Low-dose naltrexone (LDN) – Review of therapeutic utilization.

    Published On: September 21, 2018

    Authors: Toljan K, Vrooman B PMID: 30248938 PMCID: PMC6313374 DOI: 10.3390/medsci6040082 Abstract Naltrexone and naloxone are classical opioid antagonists. In substantially lower than standard doses, they exert different pharmacodynamics. Low-dose naltrexone (LDN), considered in a daily dose of 1 to 5 mg, has been shown to reduce glial inflammatory response by modulating Toll-like receptor 4 [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: naltrexone

  • Reference: Current and future use of chloroquine and hydroxychloroquine in infectious, immune, neoplastic and neurological diseases: A mini review.

    Published On: August 3, 2018

    Authors: Plantone D, Koudriavtseva T PMID: 29737455 DOI: 10.1007/s40261-018-0656-y Abstract The process of finding new therapeutic indications for currently used drugs, defined as 'repurposing', is receiving growing attention. Chloroquine and hydroxychloroquine, with an original indication to prevent or cure malaria, have been successfully used to treat several infectious (HIV, Q fever, Whipple's disease, fungal infections), [...]

    Categories: I-RECOVER Long Covid, I-RECOVER Post-Vaccine

    Tags: Chloroquine, Hydroxychloroquine

Previous192021Next
FLCCC Logo with white letters
Support Us

We are a 100% donor-supported 501(c)(3) non-profit organization. Our work would not be possible without you! Help us expand our reach and share life-saving research.

Give Now
shop
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About the IMA
  • Protocols

  • Providers

  • Testimonials

  • Latest Updates

  • Newsletter Signup

Follow Us
FLCCC Logo with white letters
Contact Us
Mailing Address

Independent Medical Alliance
2001 L St. NW Suite 500
Washington, DC 20036

Media

[email protected]

Clinical Support

[email protected]

General

[email protected]

Shortcuts
  • About IMA
  • Protocols
  • Providers
  • Testimonials
  • Latest Updates
  • Newsletter Signup
Support Us
Give Now
shop
Follow Us
Disclaimer

©2020–2025 All Rights Reserved Independent Medical Alliance (IMA), formerly FLCCC Alliance. The information contained or presented on this website is for educational purposes only. Information on this site is NOT intended to serve as a substitute for diagnosis, treatment, or advice from a qualified, licensed medical professional. The facts presented are offered as information only in order to empower you – our protocol is not medical advice – and in no way should anyone infer that we, even though we are physicians, or anyone appearing in any content on this website are practicing medicine, it is for educational purposes only. Any treatment protocol you undertake should be discussed with your physician or other licensed medical professional. Seek the advice of a medical professional for proper application of ANY material on this site or our program to your specific situation. NEVER stop or change your medications without consulting your physician. If you are having an emergency contact your emergency services: in the USA that’s 911. IMA does not use SMS to conduct marketing campaigns, however, we are required to provide the following disclaimer: By providing my phone number to “IMA”, I agree and acknowledge that “IMA” may send text messages to my wireless phone number for any purpose. Message and data rates may apply. Message frequency will vary, and you will be able to Opt-out by replying “STOP”. For information on data handling, terms of use, and disclaimers, visit our Privacy Policy & Terms.

© Copyright 2026. Independent Medical Alliance (IMA), formerly FLCCC Alliance.

Page load link
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT

Ask Our Experts

Have a question you don’t see on our list? Complete the form below with a question or topic you’d like our experts to consider adding to our FAQs resource center. Questions will not be answered individually (we cannot provide medical advice or treatment through this form).

Please enable JavaScript in your browser to complete this form.
Opt In
Loading

Disclaimer: We are unable to offer individualized medical advice, diagnoses, or treatment recommendations. For any personal medical decisions, always consult with your own healthcare provider.

Join us at IMA 2026

Join us April 17-18 for IMA 2026, a two-day event in Texas covering the latest innovations, research, and forward-thinking practices shaping the future of healthcare. Earn 12.75 Continuing Education Credits!

Buy Tickets Now

Go to Top